Following the completion of the acquisition of Telstar by Syntegon and Azbil Corporation, Telstar will now become part of Syntegon's Pharma Liquid division. This provides customers with an expanded range of filling and sealing machines, isolator systems and freeze dryers for the production of antibiotics, vaccines and biologics.
„Syntegon is the global market leader for filling and isolator systems for liquid pharmaceuticals. Together with Telstar, we will further expand our portfolio of innovative technologies and sustainable solutions, strengthen our strategic growth and increase our global reach. Following the announcement of the acquisition in June, we have received very positive customer feedback and several enquiries for joint projects. This confirms that we are on the right track to become our customers“ preferred partner for seamless solutions from a single source."
Torsten TürlingCEO of the Syntegon-Group
Headquartered in Terrassa (Barcelona), Spain, Telstar has four production facilities, six technology centres and ten consulting and engineering service centres as well as sales offices around the world. By combining these competences with Syntegon's global reach, both companies are now in an even better position to offer both pharmaceutical manufacturers and contract manufacturing organisations (CMOs) Complete solutions for your production lines from a single source to offer. In addition, the joint service network will significantly expand geographical coverage, customer proximity and application expertise.
„We are very much looking forward to utilising our combined expertise for the benefit of our existing and new customers. By utilising the synergies of a strong team, we will offer our customers innovative technologies and smooth processes with a single point of contact. This will enable us to better support them in achieving long-term stability and a fast time-to-market for their medicines.“
Jordi Puig, Managing Director of Telstar
Source: Syntegon
